R. Timothy Webb

418 total citations
9 papers, 339 citations indexed

About

R. Timothy Webb is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Timothy Webb has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Timothy Webb's work include Nausea and vomiting management (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Timothy Webb is often cited by papers focused on Nausea and vomiting management (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Timothy Webb collaborates with scholars based in United States, Netherlands and Switzerland. R. Timothy Webb's co-authors include Michael Auerbach, Kenneth R. Bridges, Tudor–Eliade Ciuleanu, Winston Ueno, Richard J. Gralla, Peter T. Silberstein, Shuli Silberman, James Shao, Paul J. Hesketh and Sandra J. Meech and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Treatment Reviews and American Journal of Hematology.

In The Last Decade

R. Timothy Webb

9 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Timothy Webb United States	7	107	94	92	66	52	9	339
Chittibabu Vatte Saudi Arabia	11	42 0.4×	21 0.2×	46 0.5×	40 0.6×	43 0.8×	38	274
Nicolai Härtel Germany	8	85 0.8×	33 0.4×	26 0.3×	51 0.8×	22 0.4×	21	240
ML Patchen United States	8	102 1.0×	97 1.0×	13 0.1×	179 2.7×	16 0.3×	11	380
Ming Zhai China	10	55 0.5×	72 0.8×	43 0.5×	36 0.5×	12 0.2×	22	278
Maria DeMol Switzerland	4	19 0.2×	204 2.2×	70 0.8×	78 1.2×	85 1.6×	4	318
Abraham Bayer United States	9	28 0.3×	89 0.9×	22 0.2×	151 2.3×	27 0.5×	18	366
Laurent Klapholz Israel	7	68 0.6×	28 0.3×	103 1.1×	8 0.1×	19 0.4×	14	245
Claire Jones United Kingdom	3	42 0.4×	49 0.5×	54 0.6×	52 0.8×	11 0.2×	9	259
James P. O’Callaghan Australia	8	24 0.2×	72 0.8×	18 0.2×	99 1.5×	28 0.5×	9	340
Kanyalakshmi Ayyanar United States	7	83 0.8×	16 0.2×	14 0.2×	52 0.8×	18 0.3×	10	351

Countries citing papers authored by R. Timothy Webb

Since Specialization

Citations

This map shows the geographic impact of R. Timothy Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Timothy Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Timothy Webb more than expected).

Fields of papers citing papers by R. Timothy Webb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Timothy Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Timothy Webb. The network helps show where R. Timothy Webb may publish in the future.

Co-authorship network of co-authors of R. Timothy Webb

This figure shows the co-authorship network connecting the top 25 collaborators of R. Timothy Webb. A scholar is included among the top collaborators of R. Timothy Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Timothy Webb. R. Timothy Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Li, Chao, Lowell L. Hart, Taofeek K. Owonikoko, et al.. (2021). Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer. Cancer Chemotherapy and Pharmacology. 87(5). 689–700. 14 indexed citations

Raez, Luis E., et al.. (2013). A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC). Cancer Chemotherapy and Pharmacology. 72(5). 1103–1110. 9 indexed citations

Aapro, Matti, Hans‐Joachim Schmoll, Franziska Jahn, Alexandra D. Carides, & R. Timothy Webb. (2012). Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types. Cancer Treatment Reviews. 39(1). 113–117. 23 indexed citations

Hirsh, Vera, Luis Paz‐Ares, Michael Boyer, et al.. (2011). Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(19). 2667–2674. 116 indexed citations

Adams, Laurel M., Brendan M. Johnson, John W. Bauman, et al.. (2010). Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer. Cancer Chemotherapy and Pharmacology. 67(4). 783–790. 5 indexed citations

Auerbach, Michael, Peter T. Silberstein, R. Timothy Webb, et al.. (2010). Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia. American Journal of Hematology. 85(9). 655–663. 71 indexed citations

Hagenstad, Christopher, et al.. (2006). A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7127–7127. 13 indexed citations

Hesketh, Paul J., et al.. (1999). Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-Induced Emesis. Journal of Clinical Oncology. 17(1). 338–338. 86 indexed citations

Hutchins, Laura F., et al.. (1988). Penetrating Duodenal Ulcer from Hepatic Artery Chemotherapy Infusion Catheter. Journal of Clinical Gastroenterology. 10(4). 434–436. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact